160 related articles for article (PubMed ID: 26613055)
1. Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix.
Ong SY; Taverna J; Jokerst C; Enzler T; Hammode E; Rogowitz E; Green MR; Babiker HM
Case Rep Oncol Med; 2015; 2015():212543. PubMed ID: 26613055
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Intravascular Coagulation and Excessive Fibrinolysis (DIC XFL) Syndrome in Prostate Cancer: A Rare Complicated Disorder.
Hamzah AB; Choo YM; Hassali MA; Saleem F; Verma AK
J Clin Diagn Res; 2017 Jan; 11(1):XD01-XD02. PubMed ID: 28274032
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report.
Giszas B; Fritzenwanger M; Grimm MO; Stallmach A; Reuken PA
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292031
[TBL] [Abstract][Full Text] [Related]
4. Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature.
Hyman DM; Soff GA; Kampel LJ
Oncology; 2011; 81(2):119-25. PubMed ID: 21986538
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic Acid to Treat Life-threatening Hemorrhage in Prostate Cancer Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis.
Prokopchuk-Gauk O; Brose K
Cureus; 2015 Dec; 7(12):e428. PubMed ID: 26848417
[TBL] [Abstract][Full Text] [Related]
6. Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer.
Ghallab M; Ilyas U; Tran L; Amin T; Abdelmoteleb S
Cureus; 2022 Oct; 14(10):e30502. PubMed ID: 36415381
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Intravascular Coagulation as the Initial Presentation of Metastatic Prostate Adenocarcinoma.
Greenberg DJ
Cureus; 2021 May; 13(5):e14845. PubMed ID: 34104590
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy, following medical therapy, for carcinoma of the prostate.
Bern MM
Hematology; 2005 Feb; 10(1):65-8. PubMed ID: 16019449
[TBL] [Abstract][Full Text] [Related]
10. Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid.
Cooper DL; Sandler AB; Wilson LD; Duffy TP
Cancer; 1992 Aug; 70(3):656-8. PubMed ID: 1623480
[TBL] [Abstract][Full Text] [Related]
11. Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer.
Duran I; Tannock IF
J Gen Intern Med; 2006 Nov; 21(11):C6-8. PubMed ID: 17026724
[TBL] [Abstract][Full Text] [Related]
12. [Disseminated intravascular coagulation--pathophysiology].
Matsuda T
Nihon Rinsho; 1993 Jan; 51(1):15-20. PubMed ID: 8433509
[TBL] [Abstract][Full Text] [Related]
13. Massive Bleeding as the First Clinical Manifestation of Metastatic Prostate Cancer due to Disseminated Intravascular Coagulation with Enhanced Fibrinolysis.
Palma Anselmo M; Nobre de Jesus G; Lopes JM; Victorino RM; Meneses Santos J
Case Rep Hematol; 2016; 2016():7217915. PubMed ID: 27803823
[TBL] [Abstract][Full Text] [Related]
14. A super-elderly case of abdominal aortic aneurysm associated with chronic disseminated intravascular coagulation.
Otsui K; Yamamoto M; Aoki H; Ozawa T; Domoto K; Suzuki A; Iwata S; Takei A; Inamoto S; Inoue N
J Cardiol Cases; 2015 Feb; 11(2):48-51. PubMed ID: 30534257
[TBL] [Abstract][Full Text] [Related]
15. Menstruation-related disseminated intravascular coagulation in an adenomyosis patient: case report and review of the literature.
Cernogoraz A; Schiraldi L; Bonazza D; Ricci G
Gynecol Endocrinol; 2019 Jan; 35(1):32-35. PubMed ID: 30044152
[TBL] [Abstract][Full Text] [Related]
16. Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer.
Malato A; Saccullo G; Coco LL; Caracciolo C; Raso S; Santoro M; Zammit V; Siragusa S
Am J Hematol; 2012 Feb; 87(2):230-2. PubMed ID: 22228308
[TBL] [Abstract][Full Text] [Related]
17. Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer.
Steinberg M
Clin Ther; 2009; 31 Pt 2():2312-31. PubMed ID: 20110043
[TBL] [Abstract][Full Text] [Related]
18. Degarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis.
Hosseini SA; Rajabi F; Akbari Sari A; Ayati M; Heidari S; Ghamary F
Med J Islam Repub Iran; 2016; 30():317. PubMed ID: 27390687
[TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
[TBL] [Abstract][Full Text] [Related]
20. [A CASE OF DISSEMINATED INTRAVASCULAR COAGULATION CAUSED BY ADVANCED PROSTATE CANCER].
Fukazawa T; Tabei T; Nirei T; Shinoki R; Tsutsumi S; Imano M; Ito H; Kobayashi K
Nihon Hinyokika Gakkai Zasshi; 2020; 111(3):94-97. PubMed ID: 34305095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
